Navigation Links
K-State Preparing to Share Expertise With Bioscientists
Date:2/28/2008

OLATHE, Kan., Feb. 28 /PRNewswire-USNewswire/ -- Aided by the Kansas Bioscience Authority, Kansas State University is gearing up to go national with specialized training programs that will keep research laboratories safe and secure -- so Americans can continue enjoying the benefits of cutting-edge, world-class research to combat infectious diseases.

Bioscience research and industry have grown significantly in recent years, leading to unprecedented demand for biosafety and biocontainment training, according to Tom Thornton, president of the KBA.

"Kansas is positioned to capture a large piece of the training market with the unique combination of expertise and facilities available at K-State's state-of-the-art Biosecurity Research Institute," Thornton said. "In fact, the demand has come knocking at our door."

Because of its research and training capabilities, the BRI recently was selected to host the National Biosafety and Biocontainment Training Program sponsored by the National Institutes of Health, which recognizes the BRI as a designated training facility for operations and maintenance training. Kansas is also one of five finalists for the National Bio and Agro-Defense Facility with its proposed site at K-State.

U.S. Sen. Pat Roberts said K-State lab training programs will help keep researchers and their communities safe.

"In Kansas, we know very well the risks of diseases attacking our crops, our livestock, and even human health, and we also know a great deal about safe and secure research to combat those diseases," Roberts said. "Now we will have the chance to share our expertise broadly and benefit the entire country."

The KBA is supporting the new Biosecurity Research Institute Training and Education Program with more than $1.5 million in funding, which will equip an integrated training suite with high-resolution video and audio equipment for transmission to training rooms and recordings. The BRI also has a lecture hall and other learning facilities.

Gov. Kathleen Sebelius said, "With this investment, Kansas continues to build our reputation as a leader in biosecurity, yet another aspect of bioscience to which we are strongly committed."

About the KBA

The Kansas Bioscience Authority is a $581-million initiative created by the Kansas Economic Growth Act of 2004 to expand the state's world-class research capacity and bioscience clusters; support the growth of bioscience startups; and stimulate bioscience business expansion and attraction.


'/>"/>
SOURCE Kansas Bioscience Authority
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. K-States Subbaratnam Muthukrishnan and Barbara Valent Named Fellows of the American Association for the Advancement of Science
2. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
3. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
4. ISS Recommends Pharmion Shareholders Vote for Merger With Celgene
5. Boom in Older-Mom Trend Drives Bay Area IVF Experts to Launch Shared-Egg Program
6. QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
7. Share Issue Gives Cellectricon SEK 89 Million to Continue its Rapid Market Expansion
8. PPD Announces Plan to Repurchase Shares of its Common Stock
9. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
10. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
11. Announcement in Relation to the Movement in the ClinPhone Share Price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... , ... PMG Research is pleased to announce its participation in ... Forum in Boston on April 3-4, 2017. The CTC conference focuses on how the ... bring them closer to the patient. Clinical Trial Collaborations also will present an inaugural ...
(Date:3/27/2017)... -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, ... Welch , will be presenting at this year,s MicroCap ... at the Essex House in New York ... Mark Erlander , Ph.D., will also be available ... The presentation will be webcast live at http://wsw.com/webcast/microcapconf3/trov ...
(Date:3/27/2017)... YORK , March 27, 2017 ... developing novel therapies for neurodegenerative diseases, including Alzheimer,s ... that its application to list the Company,s common ... approved by The NASDAQ Stock Market, a unit ... the listing, Neurotrope will ring the Opening Bell at ...
(Date:3/24/2017)... ROCKVILLE, Md. , March 24, 2017  Infectex ... Fund (MBVF), today announced positive results of a Phase ... drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis ... by scientists at Sequella, Inc. ( USA ... A total of 140 patients were enrolled ...
Breaking Biology Technology:
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 8.8% over the next decade to reach approximately $14.21 ... market estimates and forecasts for all the given segments on global ...
(Date:3/22/2017)... 21, 2017 Vigilant Solutions , a ... enforcement agencies, announced today the appointment of retired FBI ... public safety business development. Mr. Sheridan brings ... including a focus on the aviation transportation sector, to ... position, Mr. Sheridan served as the Aviation Liaison Agent ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial ... ...
Breaking Biology News(10 mins):